Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Poxel    POXEL   FR0012432516

POXEL

(POXEL)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations
Sector news Bio Therapeutic Drugs
05:28pSanofi ends research in diabetes, narrows units to spur profit
RE
03:29pGILEAD SCIENCES : Says Findings Positive From Real-World Use of Yescarta in Lymp..
DJ
12/06Glencore Faces U.K. Bribery Probe -- WSJ
DJ
12/05REGENERON PHARMACEUTICALS : Reports Positive Phase 2 Data for Pozelimab in PNH
DJ
12/04Glencore to Change 'Old Guard' Ahead Of CEO Transition -- WSJ
DJ
11/28Novartis's $90 million Swiss factory to help solve cell therapy bottleneck
RE
11/28China's major shareholders sell A-shares, pressuring markets
RE
11/27REGENERON PHARMACEUTICALS : Early Drug Treatment Sharply Reduces Deaths From Ebo..
DJ
11/25Global Blood Therapeutics' Sickle Cell Drug Gets Accelerated Approval From FD..
DJ
11/25Global Blood Therapeutics' Sickle Cell Drug Gets Accelerated Approval From FD..
DJ
11/25Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug make..
RE
11/23Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billio..
RE
11/22EXCLUSIVE : Sanofi's strategy boss to leave as CEO readies revamp
RE
11/22EUROPEAN PRESS ROUNDUP : Sanofi Cuts Less Jobs Than Planned, Qiagen's Co-Founder..
DJ
11/19Akcea, Ionis Close Licensing Agreement with Pfizer on New Drug
DJ
11/19GENMAB : EC Approves Expanded Darzalex Use in Multiple Myeloma
DJ
11/18A lot happening on the M&A side
11/18Qiagen shares surge as diagnostics group says open to takeover talks
RE
11/14BEIGENE : FDA Gives Accelerated Approval to BeiGene's Brukinsa
DJ
11/14Walt Disney soars while Cisco disappoints
11/14THERMO FISHER SCIENTIFIC : Qiagen Shares Surge on Report Thermo Fisher Mulling D..
DJ
11/07GILEAD SCIENCES : U.S. Sues HIV Drugmaker Gilead Alleging It Infringed on PrEP P..
DJ
11/07GILEAD SCIENCES : U.S. Sues HIV Drugmaker Gilead Alleging It Infringed on PrEP P..
DJ
11/06Biogen Adding Ophthalmology Biosimilars in Deal With Samsung Bioepis
DJ
11/06CELLTRION : 3Q Net Profit Rose 13% on Year
DJ
11/05Regeneron Pharmaceuticals Up Over 9%, on Pace for Largest Percent Increase Si..
DJ
11/05REGENERON PHARMACEUTICALS : Board Approves $1 Billion Buyback
DJ
11/05Regeneron Pharmaceuticals Reports Higher 3Q Profit
DJ
11/05SoftBank's Tech Problems Widen -- WSJ
DJ
11/04Snakes and ladders - SoftBank Vision Fund's climbing, sliding valuations
RE
11/01Amgen To Invest In Chinese Biotech -- WSJ
DJ
10/31Amgen to Buy Stake in Chinese Cancer-Drugmaker BeiGene -- Update
DJ
10/31AMGEN : BeiGene ADSs Up 23% on Amgen Deal
DJ
10/31Amgen takes 20.5% stake in BeiGene to sell cancer drugs in China
RE
10/31AMGEN : to Buy Stake in Chinese Cancer-Drugmaker BeiGene -- Update
DJ
10/31AMGEN : to Buy Stake in Chinese Cancer-Drugmaker BeiGene
DJ
10/30Merck loses bid to revive $2.54 billion patent verdict against Gilead
RE
10/29SANOFI : Regeneron Gets EU OK for Expanded Dupixent Use
DJ
10/25Amgen Cuts Cholesterol Treatment's Price -- WSJ
DJ
10/24GILEAD SCIENCES : Narrows FY19 Product-Sales Target
DJ
10/24GILEAD SCIENCES : Swings to Loss as Galapagos Collaboration Weighs on Quarter
DJ
10/23GILEAD SCIENCES : Likely to Post Lower 3Q Profit -- Earnings Preview
DJ
10/18GRAPHIC - TAKE FIVE : Super Saturday, Super Mario
RE
10/18TODAY'S LOGISTICS REPORT : Fred Smith's Growing FedEx Challenge; Seeking Rail Vo..
DJ
10/18JOHNSON & JOHNSON : Genmab, Janssen Get CHMP Positive Option for Expanded Darzal..
DJ
10/18European Businesses Give Draft Deal Cautious Welcome -- WSJ
DJ
10/17Prospects for a Brexit Deal Cheer Businesses, but Big Questions Remain
DJ
10/17Yacht maker Ferretti's cancellation caps dismal European IPO season
RE
10/17GLOBAL MARKETS LIVE : Nestlé, Netflix, Huawei, General Motors…
10/16INCYTE : Says Phase 3 REACH2 Trial Meets Endpoint
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on POXEL